JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB91273

Recombinant Hepatitis B Virus E Antigen protein

Be the first to review this product! Submit a review

|

(7 Publications)

Recombinant Hepatitis B Virus E Antigen protein is a Fragment protein, in the 8 to 165 aa range, expressed in Escherichia coli, with >95%, suitable for SDS-PAGE, ELISA, WB, FuncS.

Key facts

Purity

>95% SDS-PAGE

Expression system

Escherichia coli

Tags

GST tag N-Terminus

Applications

SDS-PAGE, WB, FuncS, ELISA

applications

Biologically active

Yes

Biological activity

ab91273 is immunoreactive with sera of HBV-infected individuals. It contains the Hepatitis B Virus HBe adw immunodominant region.

Animal free

No

Carrier free

No

Storage buffer

pH: 8 Constituents: 50% Glycerol (glycerin, glycerine), 0.79% Tris HCl, 0.35% Sodium chloride, 0.307% Glutathione, 0.25% Sodium-N-Lauroylsarcosinate

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "ELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "FuncS": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"" } } }

Sequence info

[{"sequence":"SKLCLGWLWGMDIDPYKEFGATVELLSFLPSDFFPSVRDLLDTASALYREALESPEHCSPHHTALRQAILCWGELMTLATWVGNNLEDPASRDLVVNYVNTNMGLKIRQLLWFHISCLTFGRETVLEYLVSFGVWIRTPPAYRPPNAPILSTLPETTV","proteinLength":"Fragment","predictedMolecularWeight":"43.7 kDa","actualMolecularWeight":null,"aminoAcidEnd":165,"aminoAcidStart":8,"nature":"Recombinant","expressionSystem":null,"accessionNumber":null,"tags":[{"tag":"GST","terminus":"N-Terminus"}]}]

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle
True

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Hepatitis B virus e antigen often referred to as HBeAg is a secreted protein associated with the hepatitis B virus (HBV) infection. It derives from the precore protein and has a role distinct from that of the HBV surface antigen (HBsAg). The molecular weight of HBeAg typically ranges around 17-25 kDa. The protein is expressed in the liver of infected individuals and can be detected in the bloodstream serving as a marker of active viral replication and infectivity. The presence of HBeAg often indicates a high level of virus production.
Biological function summary

HBeAg acts as an immune modulator influencing the host's immune response during infection. It is not part of any known complex but functions to downregulate the host's immune system promoting chronic infection. Hepatitis B virus proteins including core and surface proteins are produced in the replication process and play important roles in viral life cycle and pathogenesis. HBeAg assists in maintaining HBV persistence by helping the virus evade the immune system prolonging infection in hepatocytes.

Pathways

Multiple biological mechanisms control the expression and function of HBeAg. It is notably involved in the HBV replication cycle interacting with other HBV proteins like core and polymerase in the cytoplasmic assembly of new virions. The protein also impacts the immune signaling pathways affecting cytokine production and T-cell mediated immune responses. Such interactions enable the virus to establish long-term infection and avoid premature clearance by the immune system.

HBeAg is closely linked to chronic hepatitis B infection and liver disease progression. Persistent presence of HBeAg indicates a higher risk of developing liver-related complications such as cirrhosis and hepatocellular carcinoma. Besides its own role HBeAg influences hepatic pathogenesis in conjunction with other HBV proteins like HBV surface antigen (HBsAg) which also serves as a marker for infection. Understanding the roles of these viral proteins is important in devising treatment strategies for HBV-related liver diseases.

Specifications

Form

Liquid

Additional notes

Affinity purified.

General info

Product protocols

Publications (7)

Recent publications for all applications. Explore the full list and refine your search

Acta tropica 260:107405 PubMed39288888

2024

Up-regulation of MDSCs accumulation and Th2 biased response to co-stimulation of CsESP from Clonorchis sinensis and HBeAg in vitro.

Applications

Unspecified application

Species

Unspecified reactive species

Qiannan Liu,Nian Wang,Hengchang Sun,Huimin Dong,Xuerong Li,Xinbing Yu,Yan Huang

BMC medicine 19:247 PubMed34649530

2021

HBeAg mediates inflammatory functions of macrophages by TLR2 contributing to hepatic fibrosis.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaoyu Xie,Huanran Lv,Chenxi Liu,Xiaonan Su,Zhen Yu,Shouyang Song,Hongjun Bian,Miaomiao Tian,Chengyong Qin,Jianni Qi,Qiang Zhu

Molecular medicine reports 23: PubMed33760167

2021

MicroRNA‑1271‑5p alleviates the malignant development of hepatitis B virus‑mediated liver cancer via binding to AQP5.

Applications

Unspecified application

Species

Unspecified reactive species

Zhigang Li,Lin Ma,Lingling Di,Xutao Lin

Journal of cellular and molecular medicine :10935-10945 PubMed32767729

2020

Negative feedback loop of ERK/CREB/miR-212-3p inhibits HBeAg-induced macrophage activation.

Applications

Unspecified application

Species

Unspecified reactive species

Wenjun Chen,Hongjun Bian,Xiaoyu Xie,Xia Yang,Benjun Bi,Chunliu Li,Yuejuan Zhang,Qiang Zhu,Jing Song,Chengyong Qin,Jianni Qi

Journal of hepatology 71:252-264 PubMed30905683

2019

KLRG1+ natural killer cells exert a novel antifibrotic function in chronic hepatitis B.

Applications

Unspecified application

Species

Unspecified reactive species

Ratna S Wijaya,Scott A Read,Stephen Schibeci,Mohammed Eslam,Mahmoud K Azardaryany,Korri El-Khobar,David van der Poorten,Rita Lin,Lawrence Yuen,Vincent Lam,Jacob George,Mark W Douglas,Golo Ahlenstiel

Molecular medicine reports 19:1833-1839 PubMed30592291

2018

HBV infection suppresses the expression of inflammatory macrophage miR‑210.

Applications

Unspecified application

Species

Unspecified reactive species

Feifei Li,Hongjun Bian,Wenwen Wang,Liping Ning,Miao Xu,Shuohuan Sun,Wanhua Ren,Chengyong Qin,Jianni Qi

PloS one 10:e0130481 PubMed26103625

2015

Establishment of Magnetic Microparticles-Assisted Time-Resolved Fluoroimmunoassay for Determinating Biomarker Models in Human Serum.

Applications

Unspecified application

Species

Human

Zhi-Qi Ren,Tian-Cai Liu,Si-Hui Zhuang,Guan-Feng Lin,Jing-Yuan Hou,Ying-Song Wu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com